Bixiye
P22-20 eviCore to Become Final Reviewer on Appeals for Commercial Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Natiijooyinka Raadinta
Soo bandhiga 2651 - 2660 ee natiijooyinka 3697
Bixiye
P24-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
2020 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
QP34-20 New Claims Status Online Messaging Available on Availity
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
P19-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates - Effective May 4, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
P16-20 eviCore CPT Code Updates for Medicare Advantage Subscribers- eviCore Healthcare Specialty Utilization Management (UM) – Durable Medical Equipment
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
2020 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
P18-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
QP39-20 Commercial Pharmacy Benefit Exclusion for Beovu®, Quzyttir™, Reblozyl®, Recarbrio™ and Vyepti™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Bixiye
P21-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020